Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-02-16 to 2022-03-10
Current total value of award: $59751.58
Description: 4556447407!TYSABRI 300 MG/15 ML VIAL 15ML